Ingevity Corp (NGVT) 8-K Current Report: February 23, 2026
Filed: February 23, 2026
Health Care
Chemicals & Allied ProductsIngevity Corp (NGVT) 8-K current report filed with SEC EDGAR on February 23, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 5.02: Departure/Election of Directors or Officers
Ingevity Corp 8-K Feb 23, 2026 Event Analysis
Item 5.02 · Departure/Election of Directors or Officers
- • Jean S. Blackwell not standing for re-election at 2026 Annual Meeting; departure voluntary, no disagreement with company
- • Daniel F. Sansone also departing per mandatory retirement age policy in corporate governance guidelines
- • Board shrinking from current size to 9 directors effective at 2026 Annual Meeting — two simultaneous departures driving the reduction
- • No replacements announced; smaller board may signal leaner governance structure or pending director search
Other Ingevity Corp 8-K Filings
Get deeper insights on Ingevity Corp
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.